- Home
- UCTT vs SLXNW Comparison
UCTT vs SLXNW Comparison
Compare UCTT & SLXNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCTT
- SLXNW
- Stock Information
- Founded
- UCTT 1991
- SLXNW N/A
- Country
- UCTT United States
- SLXNW Israel
- Employees
- UCTT N/A
- SLXNW N/A
- Industry
- UCTT Semiconductors
- SLXNW
- Sector
- UCTT Technology
- SLXNW
- Exchange
- UCTT Nasdaq
- SLXNW Nasdaq
- Market Cap
- UCTT N/A
- SLXNW N/A
- IPO Year
- UCTT 2004
- SLXNW N/A
- Fundamental
- Price
- UCTT $33.97
- SLXNW $0.02
- Analyst Decision
- UCTT Strong Buy
- SLXNW
- Analyst Count
- UCTT 4
- SLXNW 0
- Target Price
- UCTT $57.75
- SLXNW N/A
- AVG Volume (30 Days)
- UCTT 531.5K
- SLXNW N/A
- Earning Date
- UCTT 10-28-2024
- SLXNW N/A
- Dividend Yield
- UCTT N/A
- SLXNW N/A
- EPS Growth
- UCTT 3479.69
- SLXNW N/A
- EPS
- UCTT 0.07
- SLXNW N/A
- Revenue
- UCTT $1,979,000,000.00
- SLXNW N/A
- Revenue This Year
- UCTT $23.09
- SLXNW N/A
- Revenue Next Year
- UCTT $12.97
- SLXNW N/A
- P/E Ratio
- UCTT $425.19
- SLXNW N/A
- Revenue Growth
- UCTT 6.62
- SLXNW N/A
- 52 Week Low
- UCTT $25.65
- SLXNW N/A
- 52 Week High
- UCTT $56.47
- SLXNW N/A
- Technical
- Relative Strength Index (RSI)
- UCTT 41.28
- SLXNW N/A
- Support Level
- UCTT $34.37
- SLXNW N/A
- Resistance Level
- UCTT $35.83
- SLXNW N/A
- Average True Range (ATR)
- UCTT 1.74
- SLXNW 0.00
- MACD
- UCTT -0.11
- SLXNW 0.00
- Stochastic Oscillator
- UCTT 27.71
- SLXNW 0.00
About SLXNW Biomotion Sciences Warrant
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.